Egalet Corporation

egalet, a fully integrated specialty pharmaceutical company, is focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions. egalet has three approved products: arymo™ er (morphine sulfate) extended-release tablets for oral use only –cii, developed using egalet’s proprietary guardian™ technology, oxaydo® (oxycodone hci, usp) tablets for oral use only –cii and sprix® (ketorolac tromethamine) nasal spray. using guardian technology egalet is developing a pipeline of clinical-stage, product candidates including egalet-002, an abuse-deterrent, extended-release, oral oxycodone formulation for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. guardian technology can be applied broadly across different classes of pharmaceutical products and can be used to develop combination products that include multiple active pharmaceutical ingredient